References
- Kimby E, Treon SP, Anagnostopoulos A, . Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia. Clin Lymphoma Myeloma 2006;6:380–383.
- Bokemeyer C, Aapro MS, Courdi A, . EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258–270.
- Yasuda Y, Fujita Y, Matsuo T, . Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003;24:1021–1029.
- Ribatti D, Vacca A, Roccaro AM, . Erythropoietin as an angiogenic factor. Eur J Clin Invest 2003;33:891–896.
- Olujohungbe A, Handa S, Holmes J. Does erythropoietin accelerate malignant transformation in multiple myeloma? Postgrad Med J 1997;73:163–164.
- Henke M, Laszig R, Rübe C, . Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362:1255–1260.
- Leyland-Jones B; BEST Investigators and Study Group. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459–460.
- Rizzo JD, Brouwers M, Hurley P, . American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010;28:4996–5010.
- Mittelman M, Neumann D, Peled A, . Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci USA 2001;98:5181–5186.
- Lifshitz L, Tabak G, Gassmann M, . Macrophages as novel target cells for erythropoietin. Haematologica 2010;95:1823–1831.
- Thews O, Kelleher DK, Vaupel P. Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors. Cancer Res 2001;61:1358–1361.
- Stüben G, Pöttgen C, Knühmann K, . Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice. Int J Radiat Oncol Biol Phys 2003;55: 1358–1362.
- Prutchi-Sagiv S, Golishevsky N, Oster HS, . Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease? Br J Haematol 2006;135:660–672.
- Littlewood TJ, Bajetta E, Nortier JW, .; Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865–2874.
- Dimopoulos MA, Gertz MA, Kastritis E, . Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. J Clin Oncol 2009;27:120–126.